BRIDGEBIO PHARMA LLC / VIKING GLOBAL OPPORTUNITIES / PERCEPTIVE LIFE SCIENCES / KKR & CO / JANUS CAPITAL MANAGEMENT LLC / AISLING CAPITAL LLC / AIG ASSET MANAGEMENT (U.S.) LLC / Acquisition / Private

Synopsis

Equity investment by KKR Genetic Disorder in BridgeBio Pharma, a developer of precision medicinal therapies for the treatment of genetic pediatric diseases.

Principals

target

Bridgebio Pharma

bidder

Aig Asset Management (u.s.)

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

josh dubofsky

Latham & Watkins

Lawyer

target

Deals

£ 182.05 B

Total Value

Bidder Team (1)